FDA authorizes infusion pump to deliver nebulized medicine
The Food and Drug Administration Monday authorized emergency use of an infusion pump system to deliver nebulized medications to patients with or suspected of having COVID-19, and reduce health care provider exposure to the patient.
Related News Articles
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Blog
America’s hospitals and health systems, regardless of size, location and ownership type, provided essential care to their patients and communities during the…
Perspective
The Senate Health, Education, Labor & Pensions Committee last week held a hearing aptly titled “Examining Health Care Workforce Shortages: Where Do We Go…